Blog
RSS FeedPosted by Michael Wonder on 21 Dec 2022
Ontario expanding safe use of biosimilars
20 December 2022 - Transitioning to biosimilars will allow province to invest in and improve access to medicines. ...
Posted by Michael Wonder on 20 Dec 2022
A National Medicines Policy fit for the future
20 December 2022 - An updated and strengthened National Medicines Policy has been delivered to the Australian Government. ...
Posted by Michael Wonder on 20 Dec 2022
Just released National Medicines Policy sets high ambitions for better health outcomes for all Australians
20 December 2022 - Medicines Australia congratulates the Government on the release of the much anticipated National Medicines Policy, after ...
Posted by Michael Wonder on 20 Dec 2022
Refreshed National Medicines Policy
20 December 2022 - The Australian Government has released an updated and strengthened National Medicines Policy. ...
Posted by Michael Wonder on 24 Oct 2022
Saskatchewan becomes sixth Canadian province to implement a biosimilar switching policy
21 October 2022 - Saskatchewan joined five provinces and one territory in implementing a biosimilar switching policy, allowing for reference ...
Posted by Michael Wonder on 26 Sep 2022
National Medicines Policy draft strides ahead but still room for improvement
26 September 2022 - Stakeholders have until tomorrow night to submit their feedback on the refreshed National Medicines Policy that ...
Posted by Michael Wonder on 05 Sep 2022
New PM will ‘inherit an NHS in its most challenging state for decades’
5 September 2022 - Warning comes from NHS leaders as new Prime Minister prepares to move into Number 10. ...
Posted by Michael Wonder on 03 Sep 2022
Every life is worth the same, but maybe not at PHARMAC
4 September 2022 - One of the dubious consequences of our obsession with race is the collection of data on ...
Posted by Michael Wonder on 22 Aug 2022
National Medicines Policy review – registrations for targeted stakeholder consultation sessions and open public forum
22 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on the revised ...
Posted by Michael Wonder on 18 Aug 2022
Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes
18 August 2022 - Medicines Australia welcomes the restart of the National Medicines Policy Review, which was put on hold ...
Posted by Michael Wonder on 17 Aug 2022
Restart of the National Medicines Policy review – further consultation on a revised draft
17 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised ...
Posted by Michael Wonder on 14 Aug 2022
Revealed: sick state of bulk-billing
15 August 2022 - Doctors expect the national bulk-billing rate may plunge to as little as 30% within two years ...
Posted by Michael Wonder on 11 Jul 2022
CADTH Advisory Panel report recommends framework for potential pan-Canadian formulary
11 July 2022 - In July 2021, the Government of Canada approached CADTH to develop a recommended framework for creating and ...
Posted by Michael Wonder on 03 Jul 2022
Health Ministers and Health Chief Executives met today in Canberra to discuss priorities for the Australian health system
1 July 2022 - Health Ministers and Health Chief Executives met today in Canberra to discuss priorities for the Australian health ...
Posted by Michael Wonder on 09 Jun 2022
PHARMAC joins ACT’s call for a medicines strategy
8 June 2022 - “It appears that everyone wants a dedicated Medicines Strategy apart from Andrew Little, who is too ...